Inhibiting the endoplasmic reticulum stress response enhances the effect of doxorubicin by altering the lipid metabolism of liver cancer cells.

Publication Year: 2023

DOI:
10.1016/j.molmet.2023.101846

PMCID:
PMC10755054

PMID:
38030123

Journal Information

Full Title: Mol Metab

Abbreviation: Mol Metab

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Metabolism

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"data availability i have attached the raw data as supplementary material appendix a supplementary data to this article can be found online at https://doi"

Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"This research was funded by The Swedish Cancer Foundation (Cancerfonden), grant numbers 20 1076PjF, 20 0175 F, and CAN2018/602; The Swedish Society for Medical Research (SSMF), grant number S17-0092; The Swedish Research Council (Vetenskapsrådet), grant numbers 2018-03301 and 2020-02367, and the Göran Gustafsson foundation. None of the funders have played a role in study design, collection, analyses and interpretation of data, writing or decision to submit this article."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025